(TCAF) T. Rowe Price - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US87283Q8675 • Large Blend
TCAF: Large, Cap, Equity, U.S.,Blend
T. Rowe Price Exchange-Traded Funds, Inc. (NYSE ARCA:TCAF) is an exchange-traded fund designed to provide exposure to equity securities, with a primary focus on large U.S. companies. The fund typically allocates at least 80% of its net assets to equity investments, which may include common stocks of businesses spanning various market capitalizations. While it maintains flexibility to invest in companies of any size, its portfolio is predominantly composed of large-cap U.S. equities. The fund is non-diversified, meaning it may concentrate its holdings in certain sectors or industries. Historically, it has shown significant exposure to the information technology and healthcare sectors, which are key drivers of innovation and growth in the U.S. economy.
From a technical perspective, TCAF has shown a recent price of $31.81, with a 20-day average volume of 1,395,050 shares. Its short-term moving average (SMA 20) is $31.02, while its medium-term (SMA 50) and long-term (SMA 200) averages are $32.30 and $32.84, respectively. This indicates a slight dip in the short term but overall stability in the longer term. The Average True Range (ATR) of 0.85 suggests moderate volatility. The funds assets under management (AUM) stand at $3,754.17 million, reflecting its popularity among investors seeking large-cap exposure.
Over the next three months, TCAF is expected to remain stable, with potential upside driven by its heavy exposure to information technology and healthcare sectors. The SMA 50 and SMA 200, both above the current price, suggest a bullish long-term trend. However, the recent dip below the SMA 20 could indicate short-term weakness. Support levels may emerge near $31.02, while resistance could be tested at $32.84. The ATR of 0.85 implies that price fluctuations will likely remain contained, with average daily price movements expected to stay within a narrow range.
From a fundamental perspective, the funds AUM of $3,754.17 million underscores its liquidity and investor confidence. Large U.S. companies, particularly in the technology and healthcare sectors, are expected to continue their growth trajectory, supported by strong earnings and innovation. However, macroeconomic factors such as interest rate changes and sector rotation could impact performance. Investors should monitor sector weightings and broader market trends to assess potential risks and opportunities.
Additional Sources for TCAF ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
TCAF ETF Overview
Market Cap in USD | 3,754m |
Category | Large Blend |
TER | 0.31% |
IPO / Inception | 2023-06-14 |
TCAF ETF Ratings
Growth Rating | 47.6 |
Fundamental | - |
Dividend Rating | 49.0 |
Rel. Strength | -1.66 |
Analysts | - |
Fair Price Momentum | 28.01 USD |
Fair Price DCF | - |
TCAF Dividends
Dividend Yield 12m | 0.45% |
Yield on Cost 5y | 0.57% |
Annual Growth 5y | 42.91% |
Payout Consistency | 100.0% |
TCAF Growth Ratios
Growth Correlation 3m | -90.5% |
Growth Correlation 12m | 52.8% |
Growth Correlation 5y | 90.7% |
CAGR 5y | 13.22% |
CAGR/Max DD 5y | 0.81 |
Sharpe Ratio 12m | 1.10 |
Alpha | -0.91 |
Beta | 0.877 |
Volatility | 29.47% |
Current Volume | 1205.9k |
Average Volume 20d | 1395.1k |
As of May 01, 2025, the stock is trading at USD 32.02 with a total of 1,205,853 shares traded.
Over the past week, the price has changed by +3.49%, over one month by -0.81%, over three months by -7.00% and over the past year by +10.02%.
Partly, yes. Based on ValueRay Analyses, T. Rowe Price (NYSE ARCA:TCAF) is currently (May 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 47.59 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TCAF as of May 2025 is 28.01. This means that TCAF is currently overvalued and has a potential downside of -12.52%.
T. Rowe Price has no consensus analysts rating.
According to ValueRays Forecast Model, TCAF T. Rowe Price will be worth about 31.9 in May 2026. The stock is currently trading at 32.02. This means that the stock has a potential downside of -0.34%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 31.9 | -0.3% |